S. Louise Phanstiel
Independent DirectorMs. S. Louise Phanstiel, C.P.A., has been an Independent Director of Butterfly Network, Inc. since February 2021. She has been the Independent Chairman of Myriad Genetics, Inc. since March 2020 and its Independent Director September 2009. Ms. Phanstiel served as a Partner of PricewaterhouseCoopers. LLP (formerly, Coopers & Lybrand, LLP). From 1996 to 2007, her work experience in managed care includes several positions at Anthem, Inc. (formerly WellPoint, Inc.), including president, specialty products, chief of staff to the Chairman, Chief Executive Officer and Chief Accounting Officer. Ms. Phanstiel served clients in life and property/casualty insurance, high technology and higher education at Coopers & Lybrand. Ms. Phanstiel held several important positions at WellPoint, Inc. from 1996 to 2007 and served as its President of Specialty Products from 2003 to 2007. She served as Senior Vice President and Chief of Staff and Corporate Planning in the Office of the Chairman at WellPoint, Inc. from 2000 to 2003. Ms. Phanstiel served as Senior Vice President, Chief Accounting Officer, Controller and Chief Financial Officer for all WellPoint, Inc. subsidiaries, including Blue Cross of California from 1996 to 2000. Ms. Phanstiel served as Independent Director of Verastem, Inc. since September 19, 2012 until October 16, 2018. Ms. Phanstiel serves as a Director of Cedar Sinai Health System. She served as a Director of Cedars-Sinai Health System (formerly known as Cedars-Sinai Medical Center). She served on the Board of Directors at Inveresk Research Group, Inc. and Charles River Laboratories, Inc. Ms. Phanstiel holds B.A. Degree in Accounting from the Golden Gate University and is a Certified Public Accountant.
Positions
- Company NameButterfly Network, Inc.Stock CodeBFLYPositionIndependent DirectorColleagues
- JMJoseph M. DeVivoCEO, President & Chairman of the Board
- JMJonathan M. RothbergFounder & Director
- JNJohn N. DohertyExecutive VP & CFO
- SCSteven CashmanExecutive VP & Chief Business Officer
- MCMegan CarlsonChief Accounting Officer & Senior VP of Finance & Accounting
- LMLawrence Michael RobbinsLead Independent Director
- ERElazer R. EdelmanIndependent Director
- Company NameMyriad Genetics, Inc.Stock CodeMYGNPositionIndependent Chair of the BoardColleagues
- SSSamraat S. RahaPresident, CEO & Director
- SLS. Louise PhanstielIndependent Chair of the Board
- BRBenjamin R. WheelerCFO & Principal Accounting Officer
- MSMark S. VerrattiChief Operating Officer
- DMDale MuzzeyChief Scientific Officer
- PJPaul J. DiazConsultant
- HDHeinrich DreismannIndependent Director
- CFColleen Foley ReitanIndependent Director
- MSMark S. DavisIndependent Director
